Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 401/04 (2006.01) A61K 31/454 (2006.01)

Patent

CA 2261762

Substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6- dioxopiperidin- 3-yl)isoindolines reduce the levels of TNF-alpha in a mammal. A typical embodiment is 1-oxo-2-(2,6-dioxopiperidin-3-yl)-4-aminoisoindoline, having the following formula: (see formula I)

Les 2-(2,6- dioxopipéridine-3-yl)-phtalimides substitués et les 1-oxo-2-(2,6- dioxopipéridine-3-yl)-iso-indolines substituées réduisent les taux de TNF-alpha chez le mammifère. Les formes utilisées sont en particulier 1-oxo-2-(2,6-dioxo-3-méthylpipéridine-3-yl)-4,5,6,7-tétrafluoro-iso-indoline et 1,3-dioxo-2-(2,6-dioxo-3-méthylpipéridine-3-yl)-4-amino-iso-indoline.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1669033

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.